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Mouse cells are non-permissive to human immunodeficiency virus type 1 (HIV) in that there is a pronounced post-integration block to viral
replication. We have recently demonstrated that mouse–human somatic cell hybrids that contain human chromosome 2 increase both HIV Capsid
(CA) production and infectious virus release. Here we report on the isolation of three mouse–human microcell hybrids (MCHs) that behave
similarly, starting from a pool of 500 MCH clones. Release of virus was specific to HIV and cell revertants that no longer contained any human
chromosome fragments did not release CA or infectious virus. Two of the three cell clones were identical as judged by PCR STS content and
fluorescence in situ hybridization (FISH) and contained a single 2–12 human chromosome chimera. The third cell clone only contained human
chromosome 12, as determined by PCR, FISH, and microarray analyses. There were no consistent differences in Gag protein and spliced/
unspliced viral RNA levels between mouse cell lines. CMV promoter-driven, codon-optimized gag-pol had no effect on infectious HIV release
from these mouse cells, despite allowing Gag targeting and increasing CA production. These permissive mouse–human MCHs and their
corresponding non-permissive revertants may prove useful for mechanistic studies and also for identifying the responsible gene(s) or factor(s)
involved in the production of HIV.
© 2006 Elsevier Inc. All rights reserved.Keywords: Human immunodeficiency virus; Murine model; Capsid production; Microcell hybridsIntroduction
There is no small animal model permissive for human
immunodeficiency virus type 1 (HIV) replication. For example,
after provision of the viral entry determinants (i.e., human CD4
and the appropriate chemokine co-receptor) to murine cells, the
level of transcription from the HIV long terminal repeat (LTR)
was relatively low. Identification of human cyclin T1 allowed
for greater transcriptional processivity from the LTR (Garber et
al., 1998; Wei et al., 1998) and resulted in higher amounts of
viral gene products in murine cells. Still, HIV-infected mouse⁎ Corresponding author. Baylor College of Medicine, Department of
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77030, USA. Fax: +1 713 798 3586.
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doi:10.1016/j.virol.2006.12.015cells that express human CD4, co-receptor, and cyclin T1
released only trace amounts of capsid p24 (CA) and little
infectious virus (Bieniasz and Cullen, 2000; Garber et al., 1998;
Mariani et al., 2000), suggesting the presence of a post-
integration block to HIV replication.
Because mouse–human cell fusions are more permissive to
viral replication, others have proposed that one or more
essential factors that permit completion of the viral life cycle
are absent from mouse cells (Bieniasz and Cullen, 2000). In the
presence of cyclin T1, mouse cells express both unspliced and
spliced viral RNAs, although the ratio of unspliced to spliced is
considerably lower compared to human cells (Mariani et al.,
2000). By electron microscopy, amorphous collections of Gag
accrue in the cytoplasm near or in unknown vesicular structures,
suggesting that the observed replicative block is at a post-
translational stage (Mariani et al., 2000). Neither tethered nor
Fig. 1. MCH genetic strategy. (A) MCH screen. Entire pool was first transduced
at low MOI with HIV-CIB(VSV G), selected using 10 μg/ml blasticidin, and
then broken down into smaller pools of ∼25 clones. Each smaller pool was
transfected with VSV G expression plasmid and rescued HIV titered on naive
human cells. Positive pools were broken down to single cells and the process
iterated to identify permissive clones. (B) Schematic of pHIV-CIB. Truncated
cyclin T1 is expressed as part of a bicistronic cassette along with Blasti,
blasticidin deaminase. LTR denotes long terminal repeat, G denotes gag, P
denotes pol, T denotes tat, R denotes rev, RRE denotes Rev response element,
Ψ denotes packaging signal. Gene products not to scale.
284 A.K. Coskun et al. / Virology 362 (2007) 283–293extracellular viral particles are seen in mouse cells infected with
HIV (Mariani et al., 2000), suggesting that the replication defect
is earlier than the final assembly/budding steps from the plasma
membrane.
The block to virus production in mouse cells has been
circumvented to some extent by the use of a chimeric murine
leukemia virus/HIV matrix p17 (MA) gene, although the level
of viral replication was much lower in comparison to wild-type
HIV in human cells (Chen et al., 2001; Reed et al., 2002). The
globular head of MA may actually be inhibitory to plasma
membrane binding (Perez-Caballero et al., 2004; Spearman
et al., 1997), which is likely related to the myristate switch (Ono
and Freed, 1999; Paillart and Gottlinger, 1999). Gag expression
and production of infectious virus in both human and murine
cells were increased by deletions in portions of MA
(Hatziioannou et al., 2005), although those results have not
been consistently observed by all investigators (Hubner and
Chen, 2006). These data imply that as in human cells HIV MA
may function inefficiently or actually be antagonistic in mouse
cells, but there are likely to be membrane-independent steps
required for virus assembly. Multimerization of Gag and
association at the plasma membrane was found to be highly
concentration-dependent (Perez-Caballero et al., 2004), sug-
gesting CA production and infectious virus release may be
particularly dependent upon level of Gag protein, perhaps in a
non-linear manner. Reduced CA production/release cannot be
explained by the action of mouse APOBEC3, since APOBEC
proteins are not known to interfere with Gag processing to any
significant extent.
Nuclear export and cytoplasmic translation of fully spliced,
partially spliced, and unspliced viral mRNAs are absolutely
required for proper and efficient assembly of HIV. HIV RNAs
that contain introns are exported through the action of the Rev/
Rev-response-element (RRE) pathway which involves Crm1
and Ran-GTP (Cullen, 2003). Mason-Pfizer monkey virus
(MPMV), a retrovirus, relies on a separate pathway for unspliced
mRNA export (Bray et al., 1994). Here, NFX1 (also known as
Tap) binds to the constitutive transport element (CTE) ofMPMV
and RNA export occurs via normal cellular mechanisms, but
separates from the Rev/RRE pathway. When the RRE was
replaced with a multimerized CTE from MPMV, in mouse cells
both Gag trafficking to cellular membranes and CA production
were restored (Swanson et al., 2004). Thus, in mouse cells Rev/
RRE-containing transcripts may be incorrectly trafficked after
nuclear export, perhaps because the ‘marked’ RNAs are
functionally deficient in some manner.
Previously we had used a panel mouse–human somatic cell
hybrids (SCHs) to demonstrate that the presence of chromo-
some 2 allowed efficient CA and infectious virus production
from murine cells, which was specific to HIV (Coskun et al.,
2006). This effect did not appear to be due to alterations in
cyclinT1 function and there was no clear increase in the
amounts of unspliced mRNA and Gag protein precursor.
Presence of Vpu along with chromosome 2 had only a modest
impact on infectious virus release (Coskun et al., 2006).
In parallel with the SCH genetic approach, we began with a
panel of microcell hybrids (MCHs) (Speevak et al., 1995;Speevak and Chevrette, 1996). At the time we believed that
identification and characterization of permissive MCHs would
lead to improved genomic resolution of the phenotype of
infectious HIV release. Here we report the isolation of three
MCH cell clones highly permissive for CA and infectious virus
release, which again is specific to HIV. Cells that had lost the
human chromosome also reverted their phenotype. Two of the
cell clones appear to be identical and contain a single 2–12
chromosome chimera. The third appears to contain only intact
chromosome 12. Use of codon-optimized gag-pol did not
increase infectious virus production from any of the mouse cell
lines. These cell clones and their associated revertants may
prove useful for the further study of the block to HIV replication
in murine cells.
Results
Isolation of MCH cell clones permissive to HIV release
Mouse cells release little infectious HIV. As a potential
genetic approach to this problem, a pool of 500 mouse–human
MCHs was obtained and transduced in bulk with HIV vector
pHIV-CIB pseudotyped with VSV G at lowMOI. The outline of
this screen is shown in Fig. 1A. The MCHs are also maintained
under hygromycin selection since the human chromosome
portion has an integrated, CMV-driven hygroTK gene. Parental
mouse melanoma B78 cells were also transduced. HIV-CIB
encodes all requisite cis-acting sequences along with gag, pol,
tat, rev, and a 1.9 kb bicistronic cassette encoding truncated
human cyclinT1 linked by an internal ribosome entry site to
blasticidin deaminase (Fig. 1B). In many human cell types, the
vector may be recovered or rescued simply by provision of VSV
Fig. 2. Recovery of HIV and MLV from MCHs. (A) MCHs that had been
transduced with HIV-CIB(VSV G) were transfected with VSV G at least in
triplicate and resulting supernatant titered on 293T targets. Titer was normalized
to transfection efficiency, as judged by an eYFP reporter. *P<0.05 compared to
parental B78 cells; **P>0.05 compared to parental B78 cells; R denotes
revertant. (B) MCHs that had been transduced with HIV-CIB(VSV G) were
transfected with ADA envelope and resulting supernatant titered on GHOST
HI5 targets. Titer was normalized to transfection efficiency, as judged by an
eYFP reporter. Experiment was repeated twice with similar results. Typically,
recovery of infectious HIV(ADA) from similarly transfected 293T cells was
>1000. Down arrow indicates no infectious particles were recovered from 2 ml
of supernatant in this particular experiment. (C) MCHs and 293Ts were
transfected with MLV vector encoding eGFP, VSV G, and MLV gag-pol.
Supernatant was titered on adherent human cells by epifluorescence microscopy
72 h later, normalized toB78 parental cells. Experiment was repeated with
similar results (open and closed bars). We occasionally noted variability in
recovery of infectious MLV from 293T cells, perhaps due to differences in
transfection efficiency of the three plasmids.
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naive target cells and subsequently enumerating blasticidin-
resistant colonies. After transduction, MCHs were stably
passaged in the presence of blasticidin and then subdivided
into 80 pools of ∼25 cells each. Each of these was transfected
with VSV G and the supernatant used to infect 293T cells.
Compared to the parental B78 cells, 3 of the pools reproducibly
released infectious virus. Each of these three pools was broken
down to individual cell clones, and over 150 cell clones were
tested to identify 3 (one from each pool) that repeatedly gave
efficient HIV release. These clones, designated p11, p19, and
p28, were further investigated.
MCH clones release infectious HIV and CA
The MCH clones of interest were transfected with VSV G
and infectious virus present in supernatant was titered on 293T
cells. As can be seen in Fig. 2A, the MCHs were quite
permissive for infectious HIV release, especially when
compared to the parental B78 mouse melanoma cells (negative
control) and 293Ts (positive control). In order to show that this
phenotype was due to the human chromosome(s) present, cells
were passaged at low confluency into ganciclovir along with
blasticidin S. Surviving cell colonies (arising at a frequency of
∼1 in 10,000) were pooled, tested to verify that they were now
sensitive to hygromycin, and then transfected with VSV G. The
revertant cells now released little HIV (Fig. 2A). PCR across the
genome was also performed to confirm loss of associated
human DNA (see Table 2 below). Of note, the MCH clones
were not as permissive as the 293T cells, perhaps related to
transfection efficiency, an increase in unspliced viral RNA (see
Fig. 4 below), or other unknown factors.
The MCH clones of interest were also transfected with the
M-tropic envelope ADA and released infectious virus titered on
GHOST HI5 cells. Again, the MCH cell clones were quite
permissive for HIV(ADA) release, whereas the revertants
produced little infectious virus (Fig. 2B). To demonstrate
specificity to HIV, cell clones were tri-transfected with VSV G,
pHIT60, and pBABE-IY, and released infectious MLV titered
on HOS cell targets. Although there was some variability in
MLV production, none of the MCHs had a marked increase in
amount of MLV present in the culture supernatant (Fig. 2C).
The variability of MLV release from 293T cells may best be
explained by differences in transfection efficiency from
experiment to experiment.
The negligible release of infectious HIV from mouse cells is
correlated with low amounts of CA release. Previously we had
demonstrated that SCHs that contain human chromosome 2
release significantly greater amounts of infectious HIVand CA.
Thus, we also measured the amount of CA produced from the
MCH clones, as quantified by ELISA. The absolute amounts of
CA in the tissue culture supernatants paralleled the results from
the infectious virus assays (Fig. 3A). To demonstrate that this
was not simply due to more intracellular CA in the individual
cell clones, the percentage yield of supernatant CA was also
determined, and that paralleled the other results (Fig. 3B). This
suggests that the increase in CA production observed is not
Fig. 3. CA analysis of MCHs. MCHs or 293Ts that had been stably transduced
with HIV-CIB or HIV-LIB, respectively, were plated at low density and allowed to
reach confluence. At that point equivalent amounts of supernatant and cells were
harvested for CA quantitation using commercial ELISA kit. Absolute amounts of
supernatant CA are shown in panel A. (B) Gag yield (amount of CA in the
supernatant divided by amount in cell lysate), using equivalent number of lysed
cells. R denotes revertant. This experiment was repeated with similar results.
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next section below).
Many of the MCH clones in the pool have all or a portion of
chromosome 12 present (Speevak et al., 1995; Speevak and
Chevrette, 1996 and see below). SCHs that have chromosome
12 have improved cyclin T1 function but release little infectious
virus (Coskun et al., 2006). Although the results of the genetic
screen implied that only rare MCH clones had the phenotype of
virus release, we wished to test randomly picked clones for both
presence of chromosome 12 and the ability to release HIV. AllTable 1
Random MCH clones have most of chromosome 2 but do not support HIV release
Cell line
or clone a
Titer b SHGC-123694
(12p13.32) c
SHGC-140086
(12p12.3)
SHGC-147202
(12q21.33)
293T ∼10000 + + +
M2 50 +/− + +
M3 40 + + +
M4 24 + + +
M8 93 +/− + +
M9 93 +/− + +
p28 1700 + + +
p28-Revertant ND − − −
a Cells were transduced with HIV-CIB(VSV G) and selected using blasticidin S.
b Recovery of HIV (IU/ml) after transfection of cells with VSV G, with transfecti
c + denotes presence of PCR product, − denotes absence, +/− denotes weak prod
d This marker is at position 131081841, near the tip of chromosome 12q.of the randomly picked clones had most of chromosome 12 as
determined by PCR using 8 different primer pairs spanning 12,
whereas none efficiently released HIV (Table 1). This suggests
that the mere presence of chromosome 12 is insufficient to
allow infectious virus release. Note, however, that the randomly
picked MCH clones did not amplify SHGC-81002 at 12q24.23
whereas p28 did, suggesting that there may be chromosome 12-
specific differences between the non-permissive and permissive
clones.
Quantitation of HIV nucleic acid and p55 Gag protein
It is possible that the observed results are due to increased
amounts of proviral DNA and viral RNA in the MCH clones of
interest, leading to increased Gag and CA production. In order
to determine proviral DNA copy number, genomic DNA was
prepared, and integrated viral DNAwas amplified along with β-
actin (as a normalization control) and compared against a 293T
cell clone with a single vector integrant. All of the MCH clones
examined had a single vector integrant, within the error of the
measurement (not shown).
We next examined levels of spliced and unspliced viral
RNAs. Total RNAwas prepared, reverse transcribed using oligo
(dT) as first strand primer, and PCR performed across the
foreshortened tat/rev intron as previously described (Coskun et
al., 2006), with β-actin again serving as loading control. With
these primers, the PCR product from spliced RNA is 350 bp and
from unspliced 1200 bp (see schematic at top of Fig. 4). As
shown in Fig. 4, there were no consistent differences in levels of
either spliced or unspliced viral RNAs observed between the
B78 parental cells, the MCH clones, and the revertants. We
reproducibly observed a lower ratio of unspliced to spliced viral
RNAs in the mouse cells compared to the human cells, as we
and others have reported before (Coskun et al., 2006). The ratio
of unspliced to spliced viral RNA was essentially unchanged
across the various MCH cell clones, the corresponding
revertants, and the B78 parents, with the notable exception of
p28-R, which consistently gave higher levels of unspliced viral
RNA (despite little infectious virus release).
Because there could be post-transcriptional effects, we also
examined levels of intracellular Gag by immunoblotting. RIPARH45303
(12q13.12)
SHGC-81002
(12q24.23)
SHGC-83339
(12q24.31)
SHGC-84322
(12q24.32)
RH39825
(12q24.33) d
+ + + + +
+ − + +/− +
+ − + +/− +
+ − + +/− +
− − + +/− −
− − + +/− −
+ + + + −
− − − − −
p28-Revertant was selected using ganciclovir.
on efficiency normalized using an eYFP reporter. ND denotes not determined.
uct.
Fig. 5. Cell-associated Gag in MCHs. Two-fold increasing amounts (wedges) of
cell lysates from indicated MCHs stably transduced with HIV-CIB and 293Ts
transduced with HIV-LIB (smaller wedge) were subjected to SDS-PAGE,
transferred to nitrocellulose, and immunoblotted using anti-HIV sera with
detection using ECL. P55, p41, and p24 are indicated (arrows). Lysates from
mock-transduced cells did not give rise to any HIV-specific bands.
Fig. 4. Nucleic acid analysis of MCHs. Total RNA was prepared from MCHs
and 293Ts stably transduced with HIV-CIB or HIV-LIB, respectively, and
subjected to RT-PCR, using oligo(dT) as first strand primer. At top is shown a
schematic of the region of the HIV vector amplified, with the DNA primers
(arrows) located within the tat/rev (t/r) exons (rectangles). Truncated intron is
∼900 bp. RRE denotes Rev-response element. Bottom two panels: results using
HIV primers using 3 different amounts of first strand reaction equivalent to RNA
amounts of 15, 45, and 135 ng (wedges), Southern blotted using a 0.7 kb intronic
probe (two different film exposure times; expected product of ∼1250 bp
indicated by arrow). Top panel: Results using the same primers and amounts of
first strand cDNA, with expected spliced product of 350 bp indicated by
arrowhead (EtBr stain). Unspliced products have been cropped. No products
were observed with water (H) control or in the absence of RT. These RT-PCR
experiments were repeated twice with similar results. R denotes revertant cell
line.
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by SDS-PAGE and HIV proteins detected using anti-HIV
antisera. There were no consistent differences in p55 Gag levels
observed between the various transduced mouse cell lines,
whereas there was more Gag and CA present in the 293T cells
(Fig. 5). There was also no clear increase in intracellular CA in
the MCH cell clones of interest compared to the revertants and
B78 parents. These results, taken together, suggest that the
phenotype observed in the MCH clones is not due to increased
levels of unspliced/spliced viral RNA or precursor Gag protein.
DNA and chromosomal content of MCH clones
We also determined the human chromosomal content of the
isolated MCH clones. Using a linkage mapping set consisting of
400 pairs of DNA primers spanning the human genome at
10 cM resolution, PCR was performed using genomic DNA
prepared from the MCH clones, p11 revertant, and 293Ts, the
latter serving as a positive control. Only regions of chromosome
2 and 12 consistently scored positive for the MCHs, and those
results are summarized in Table 2. MCH clones p11 and p19
appeared to be identical by this PCR-based analysis. Both had
present ∼90 Mb from chromosome 2p and 60 Mb from
chromosome 2q, with most of chromosome 12. MCH clone p28
only had what appeared to be intact chromosome 12, without
any other clearly identifiable region of the human genome
present. Although some PCR products were weakly positive forsome of the markers on chromosome 2, a more extensive
analysis using flanking markers suggested that those regions
were not present in p28 (not shown). As expected, the p11
revertant line had no portion of any human chromosome
present.
We next performed FISH on metaphase spreads of the MCH
clones. Using chromosome 2 paint, both p11 and p19 MCH
clones had an identical complex, but single human chromosome
present (Figs. 6A, B). Chromosome 12 paint also identified a
single chromosome in both p11 and p19, with the fluorescent
signal encompassing the centromeric region (not shown).
Hybridizing separate 2p and 2q labeled BACs demonstrated
that both 2p and 2q were present on opposing arms of the single
chromosome in p11 and p19 (Fig. 6C). Hybridizing a 2p BAC
and a BAC from 12 showed that they were on the same
chromosome (Fig. 6D). These results suggest that a chimeric 2–
12 chromosome is present in MCH clones p11 and p19. Similar
analyses were performed on MCH clone p28, but only
chromosome 12 was detected, and it appeared to be intact,
consistent with the PCR results (Tables 1 and 2).
Because both the genomic PCR and FISH are of relatively
low resolution, we wished to use a higher resolution method to
confirm that clone p28 only had chromosome 12 present. RNA
was prepared from p28, reverse-transcribed, labeled, and used to
probe a U133 Affymetrix microarray. cDNAs were sorted on the
basis of numerical order on each chromosome, and the results are
shown for all of the chromosomes in Fig. 7. As expected, strong
hybridizing signals were visible for the entire length of
chromosome 12, whereas there was no large, contiguous region
present for any other chromosome. Thus, all three methods are
consistent and suggest that only whole chromosome 12 is
present in MCH clone p28, although we cannot exclude very
small pieces of other human chromosomes or mosaicism.
Use of codon-optimized gag constructs
It had been reported that expression of codon-optimized gag
driven by the CMV immediate early enhancer-promoter led to
Gag accumulation at the plasma membrane in both human and
mouse cells (Hatziioannou et al., 2005; Swanson et al., 2004).
We confirmed that result in the B78 parental mouse cells (Fig.
8A). We next decided to test whether expression of CMV-
driven, codon-optimized gag-pol would allow infectious virus
release from mouse cells. B78 parental cells and MCH clones
Table 2
PCR Results from Linkage Mapping Set
Locus a Chromosome Position (bp) b p19 c p28 d p11 p11-R e 293T
D2S319 2 3,480,348–3,480,477 + − + − +
D2S2211 2 7,383,683–7,383,944 + +/− + − +
D2S162 2 8,777,748–8,777,871 + − + − +
D2S168 2 8,777,748–8,777,871 + − + − +
D2S165 2 28,456,872–28,456,976 + − + − +
D2S367 2 34,294,707–34,294,847 + − + − +
D2S2259 2 42,835,897–42,836,125 + − + − +
D2S391 2 46,265,007–46,265,152 + − + − +
D2S337 2 33,790,596–33,790,704 + +/− + − +
D2S2368 2 67,062,334–67,062,425 + − + − +
D2S286 2 75,195,641–75,195,784 + − + − +
D2S2333 2 85,316,486–85316739 + − + − +
D2S2216 2 88,190,785–88,190,917 + +/− + − +
D2S347 2 117,574,432–117,574,717 − − − − +
D2S142 2 149,896,624–149,896,883 − − − − +
D2S2330 2 160,307,545–160,307,709 − − − − +
D2S335 2 172,274,762–172,274,856 − − − − +
D2S364 2 182,742,779–182,743,014 + − + − +
D2S117 2 195,327,044–195,327,241 + − + − +
D2S325 2 207,979,115–207,979,227 + − + − +
D2S2382 2 210,818,276–210,818,514 + − + − +
D2S126 2 221,725,283–221,725,500 + − + − +
D2S396 2 230,391,872–230,392,111 + − + − +
D2S206 2 233,416,066–233,416,307 + − + − +
D2S338 2 230,948,422–230,948,710 + − + − +
D2S125 2 240,816,799–240,816,894 + − + − +
D12S352 12 531,659–531,820 + + + − +
D12S99 12 5,435,032–5,435,160 + + + − +
D12S310 12 18,864,808–18,865,059 + + + − +
D12S1617 12 24,991,299–24,991,555 + + + − +
D12S85 12 45,622,990–45,623,114 + + + − +
D12S83 12 59,175,723–59,175,935 + + + − +
D12S79 12 114,544,839–114,545,005 + + + − +
D12S86 12 117,654,705–117,654,838 + + + − +
D12S1659 12 127,982,361–127,982,460 + + + − +
D12S1723 12 130,528,689–130,528,851 + + + − +
a Non-informative loci (in which no PCR product was present or was also observed in the water control) have been omitted.
b Chromosome bp position as per UCSC genome browser, release date of March 2006.
c + denotes presence, − denotes absence of expected PCR product.
d +/− result denotes faint band present and other, immediately surrounding loci tested negative.
e R denotes pool of revertants, which was ganciclovir resistant and hygromycin sensitive.
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cells have an integrated HIV-CIB vector and already express Tat
and Rev. As previously shown by others (Hatziioannou et al.,
2005; Swanson et al., 2004), expression of the synthetic gag-
pol boosted the amount of CA released from all of the mouse
cell lines tested (Fig. 8B), but it did not increase infectious HIV
release from the B78 cells nor from any of the MCHs (Fig. 8C).
This suggests that high level expression of Gag-Pol and correct
localization of Gag at the murine plasma membrane are not
sufficient to rescue integrated HIV as an infectious particle.
Similar results had been observed in the SCHs (Coskun et al.,
2006).
Discussion
Mouse cells are not permissive for HIV replication, with a
prominent block in the latter half of the viral life cycle. Here weused a genetic strategy to isolate three MCH cell clones that
allowed efficient infectious HIV release. Production was
independent of glycoprotein envelope used and specific to
HIV. Amount of CA present in culture supernatants paralleled
infectious virus. Importantly, revertant cell clones that no longer
had any human chromosome component produced little HIV
and CA. Differences in both intracellular Gag and unspliced/
spliced viral RNA levels between the mouse cell clones were
minor or inconsistent, whereas as previously reported human
cells clearly had more unspliced relative to spliced viral RNA. A
variety of genomic and chromosomal methods indicated that
two of the three MCH clones were identical and had a single 2–
12 chimera, whereas the third had solely intact 12. Although
codon-optimized Gag-Pol was expressed at the plasma
membrane and boosted CA production in all mouse cells
tested, it could not rescue the replicative defect in that
recoverable infectious titers were unaffected.
Fig. 6. FISH analysis of MCH clones. Metaphase spreads were prepared fromMCH clones, hybridized with either chromosome-specific paint or BACs, and examined
by high power fluorescence microscopy. (A) p11 probed with chromosome 2 paint; (B) p19 probed similarly; (C) p11 probed with a 2q BAC (green) and a 2p BAC
(red); (D) p11 probed with a chromosome 2 BAC (red) and a chromosome 12 BAC (green).
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linearly with the amount of Gag due to cooperative or
concentration-dependent assembly effects (Perez-Caballero
et al., 2004), we went through some effort to show that
compared to B78 parental cells and the MCH revertants the
MCH clones (i) do not have increased proviral copy number, (ii)
have roughly equivalent quantities of intracellular precursor
Gag protein, and (iii) have approximately the same amount of
both unspliced and spliced viral RNAs (with the notable
exception of p28-R which had more unspliced viral RNA).
Importantly, transfection of codon-optimized, CMV promoter-
driven HIV gag-pol did not fully rescue the mouse cell defect,
as we had observed previously with other murine lines (Coskun
et al., 2006).
At this point, however, we cannot exclude the possibility that
slight differences in amount of unspliced RNA and p55 Gag are
in fact responsible for much higher levels of infectious virus
release, perhaps related to highly cooperative effects of Gag at
the plasma membrane (Perez-Caballero et al., 2004). Thus, it is
possible that one or more factors present on the human
chromosome component in the MCH clones influences the
amount of unspliced mRNA and Gag expression, either through
transcriptional, anti-splicing, translational, or other poorly
defined effects. It is clear that the ratio of unspliced to spliced
viral RNAs remains low, even in the permissive MCH clones
compared to the human cells, suggesting that correction of the
‘over-splicing’ phenomenon is not required to achieve reason-
able infectious virus and CA production.
Previously it had been reported that CA production could be
increased substantially in mouse cells using a viral RNA
construct with a multimerized CTE (Swanson et al., 2004).Additionally, when a CMV-driven, codon-optimized gag
plasmid was transfected into mouse cells, CA production was
boosted and Gag associated with the plasma membrane
(Hatziioannou et al., 2005; Swanson et al., 2004). Here, we
confirmed the latter results. The fact that codon-optimized Gag-
Pol did not increase infectious virus release in mouse cells
suggests that at least one additional fundamental assembly
defect may be present in mouse cells, perhaps unrelated to
membrane targeting of Gag.
Localization of unspliced, cytosolic HIV mRNA has not
been fully evaluated in human or mouse cells. In the case of
MLV, use of the ms2 phage protein binding system has
suggested unspliced RNA trafficks along an endosomal path-
way and co-localizes with Gag, dependent upon MLVenvelope
protein expression (Basyuk et al., 2003). Determinants and
required co-factors for mRNA entry into this pathway await
elucidation. Compared to MLV, HIV has additional cis-acting
nucleic acid sequences and trans-acting regulatory proteins that
function in RNA nuclear export. These may play a role in
directing unspliced RNA to a specific, post-nuclear pathway,
perhaps in addition to other cellular factors that ‘mark’ the RNA
(Swanson et al., 2004). Absence of one or more of these would
impede or reduce infectious virus release from mouse cells. It is
noteworthy that addition of a multimerized CTE to viral RNA
allowed Gag to become localized to the plasma membrane and
processed, but infectious virus was not quantified (Swanson
et al., 2004).
Previously we had reported that SCHs containing chromo-
some 2 were permissive for HIV release, whereas the SCH with
12 had enhanced cyclin T1 function but did not produce more
infectious virus. We were hoping that the MCHs would lead to
Fig. 7. Microarray analysis of MCH clone p28. Total RNA was prepared, converted to cDNA, fluorescently labeled, and used to probe a U133 Affymetrix
oligonucleotide array. Results are represented graphically as hybridization signal along each human chromosome, in numerical order per UCSC genome browser.
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nately this was not the case (likely due to the nature of the
cellular clones present in the original MCH pool). Here, two of
the three MCHs isolated by the genetic screen appeared to be
identical and had a single 2–12 chimeric chromosome, whereas
the third only had an intact 12. For unknown reasons, the
majority of the MCH clones present in this pool of 500 have a
fragment or most of 12 (Speevak et al., 1995; Speevak and
Chevrette, 1996). The fact that nearly all of the MCHs and a
small panel of randomly chosen MCHs that have most of 12 do
not support infectious virus release suggests that 12 is not
causative.
We wish to emphasize that we cannot yet rule out the
possibility that a gene on 12 is responsible for the observed
phenotype, especially since the very permissive clone p28 only
has 12 as determined by a variety of low resolution methods. Itis also conceivable that there is a small, unresolvable piece of
another chromosome in p28 or that p28 is a mosaic such that a
fraction of the cells has another chromosome fragment. For
example, the PCR primers used had an average spacing of
10 cM and the whole chromosome 2 FISH hybridization has a
resolution of ∼20 Mb, depending upon the signal amplification
methods used. The results from the U133 microarray suggest
that if p28 does have a segment of 2 it is likely no greater than a
few Mb in length, which could have been easily missed by the
PCR and FISH methods. Mosaicism at the level of 10% or less
would also have gone undetected. p28 revertants that have lost
12 and the HygroTK marker are non-permissive, suggesting
that the responsible factor(s) is genetically linked to 12 and the
selectable gene.
We now have several mouse–human hybrid cell lines, each
with a single human chromosome, that are permissive for HIV
Fig. 8. Effects of synthetic gag-pol on HIV release. (A) Parental B78 cells were
transiently transfected with codon-optimized Gag-eGFP and then subjected to
deconvolution microscopy 3 days later. (B, C) MCHs stably transduced with
HIV-CIB and 293T cells transduced with HIV-LIB were transiently transfected
with HIV-eYFP and pME-VSV G, with or without the Oxford Biomedica
synthetic Gag-Pol (SGP) plasmid. (B) Supernatant (upper panel) and cell lysate
(lower) were subjected to SDS-PAGE and immunoblotting as per Fig. 5. Lane 1:
parental B78s; 2: B78s+SGP; 3: p11; 4: p11+SGP; 5: p11-R; 6: p11-R+SGP;
7: p28; 8: p28+SGP; 9: 293Ts. Short arrows indicate CA, * indicates MA. (C)
Supernatant harvested at 48 h was titered on naive human targets. Titer was
normalized to transfection efficiency, as judged by epifluorescence microscopy
of the producers. Open bars: eYFP titer; closed bars BlastiR titer. R denotes
revertant. This experiment was repeated, with similar results.
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the gene(s) involved. Both Crm1, which binds to Rev to allow
export of RRE-containing mRNAs (Fornerod et al., 1997;
Fukuda et al., 1997), and hRIP, involved in the movement of
Rev/RRE-dependent HIV RNAs from the nuclear periphery to
the cytoplasm (Sanchez-Velar et al., 2004), are located on
opposite ends of 2. Introduction of these genes by transient
transfection into mouse cells, alone and in combination, failed
to increase CA or infectious virus release (not shown). SAM68
may cooperate with Rev/RRE to allow more efficient nuclearexport of unspliced mRNAs (Modem et al., 2005; Reddy et al.,
1999). That gene is not present in any of the MCHs or SCHs of
interest, and transient transfection of SAM68 into mouse cells
failed to increase CA or infectious HIV release (not shown).
Other genes implicated in RNA export encoded on chromosome
2 (Fang et al., 2004) have not been tested.
We and others (Ned Landau and Paul Bieniasz, personal
communications) have attempted without success direct and
exhaustive cDNA and genetic complementation approaches to
identify possible missing or altered factors in mouse cells.
Radiation-hybrid mapping using the Stanford G3 hamster-
human panel failed to achieve highly significant LOD scores
(not shown). We are now faced with the prospect of engineering
the single human chromosome present in the permissive MCHs
and SCHs to further localize the gene(s) responsible, which
could be a daunting task. These cell lines, however, may also
serve as useful reagents to mechanistically dissect the post-
integration block to HIV production in murine cells.
Materials and methods
Plasmids and viral vectors
HIV vectors pHIV-cycT1-IRES-bsd (pHIV-CIB), pHIV-
luciferase-IRES-bsd (pHIV-LIB), and pHIV-IRES-eYFP have
been described (Coskun and Sutton, 2005), as has murine
leukemia virus (MLV) vector pBABE-IY (Segall et al., 2003).
M-tropic HIV envelope ADA expression plasmid was a gift
from Dan Littman. pHIT60 is an expression construct of MLV
Gag-Pol (Soneoka et al., 1995), and pME VSV G is a VSV
glycoprotein expression plasmid. CMV-driven codon-opti-
mized (synthetic) gag-pol and gag-eGFP were gifts of Oxford
Biomedica (Kotsopoulou et al., 2000) and Paul Bieniasz,
respectively.
Cells and production of pseudotyped particles
Cells were maintained in Dulbecco's modified Eagle's high-
glucose medium supplemented with 10% fetal calf serum,
penicillin, streptomycin, and ciprofloxacin (termed DMEM
complete), with other antibiotic supplements as necessary. Cells
were grown in 5% CO2, 37 °C water-jacketed incubators and
passaged twice weekly using trypsin-EDTA. A pool of 500
MCHs were originally obtained fromMario Chevrette (Speevak
et al., 1995) and maintained in complete DMEM supplemented
with 400 μg/ml hygromycin B (Calbiochem). In order to revert
the MCHs and lose the human chromosome component, cells
were passaged at low confluency into complete DMEM plus
35 μM ganciclovir. Ganciclovir-resistant colonies typically
arose after 10–12 days at a frequency of ∼0.01% and were
shown to be sensitive to hygromycin B, consistent with loss of
the human chromosome.
Retroviral and lentiviral pseudotyped particles were pro-
duced by calcium phosphate co-transfection of 293T cells with
the appropriate viral envelope (here typically VSV G) and
vector (Sutton and Littman, 1996). For MLV, pHIT60 was also
included in the transfection. After 72 h, vector supernatant was
292 A.K. Coskun et al. / Virology 362 (2007) 283–293harvested as previously described (Sutton and Littman, 1996).
Target cells were transduced in 18 or 35 mm dish format and
48 h later passaged into selective medium (typically DMEM
complete supplemented with 10 μg/ml of blasticidin S
(Invitrogen or ICN).
In order to recover and titer integrated HIV vector encoding
bsd from cell lines, cells were plated one day prior in 35 mm
or 10 cm format, transfected the next day at high confluence with
1–2 μg each of the viral glycoprotein envelope plasmid (e.g.,
pME VSV G) along with an autofluorescent control (e.g., HIV-
IRES-eYFP) using Lipofectamine 2000 reagent (Invitrogen) and
following the manufacturer's instructions. Forty-eight hours
later culture supernatant was harvested, centrifuged at 2000×g
for 10 min, and inoculated onto adherent human targets,
typically HOS TK- or 293T cells. Transfected cells were
examined after supernatant harvest by epifluorescence micro-
scopy or subjected to flow cytometry using a FACScan (Becton-
Dickinson) to determine overall transfection efficiency. Target
human cells were passaged into DMEM complete containing
10 μg/ml of blasticidin S 2 days later. Cells were fixed in
methanol and acetic acid, stained with crystal violet, and
colonies enumerated after 7–9 days.
Analysis of CA
Amount of CA produced by vector-transduced or infected
cells was quantified by commercial ELISA (Beckman-Coulter)
or by immunoblotting. For the latter, RIPA cell lysates were
size-separated by SDS-PAGE and transferred to nitrocellulose.
Membrane was blocked using Tris-buffered saline in the
presence of 0.02% Tween-20 and 2.5% nonfat dried milk
(TBS-T+NFDM), probed using primary human anti-HIV
antibody from the AIDS Research and Reference Reagent
Program (Cat. No. 3957) at 1:1000 in the same buffer, washed
extensively in TBS-T, probed using secondary rabbit anti-
human IgG antibody conjugated to HRP (Sigma) at 1:10,000,
washed, and developed using enhanced chemiluminescence.
Nucleic acid analyses
Genomic DNA was prepared from cell lines as described
(Coskun et al., 2006). PCR for mouse and human β-actin was
performed as described (Coskun et al., 2006). HIV DNA
primers for PCR amplification were NL4-3 831L (Sutton et al.,
1998) and NL4-3 569U (Coskun et al., 2006), using conditions
94 °C for 30 s, 62 °C for 30 s, and 68 °C for 30 s for 31 cycles
and Expand Long DNA polymerase (Roche) to give rise to a
∼260 bp product, which was analyzed by agarose gel
electrophoresis and ethidium bromide staining. Positive control
cell line had a single HIV vector integrant. Gels were Southern
blotted at high stringency using the corresponding PCR product
as 32P-labeled probe, amplified from HIV vector plasmid
template.
Total RNA was prepared from cell lines as described
previously (Coskun et al., 2006). First strand reaction was
performed using Superscript II RT (Invitrogen) using 1–3 μg of
total RNA, and oligo(dT) as primer for 60 min at 42 °C. DNAPCR for both mouse and human β-actin was performed as
described above for 21 cycles using three different amounts of
first strand reaction. For HIV, primers spanning the tat-rev
intron were 5′-CTGTGGCATTGAGCAAGCTAACAGCAC-
3′ and 5′-ACAGCGACGAAGAGCTCATCAGAACAG-3′.
Amplification conditions were 94 °C for 30 s, 62 °C for 30 s,
and 68 °C for 60 s for 35 cycles using Expand Long DNA
polymerase and the equivalent of 15, 45, and 145 ng of total
RNA from the first strand reaction. This resulted in DNA
products of 1250 and 350 bp, corresponding to unspliced and
spliced viral mRNAs, respectively. The spliced 350 bp product
was directly visualized by agarose gel electrophoresis and EtBr
staining. For the unspliced product, Southern blotting was
performed using a 0.7 kb HindIII fragment specific to the intron
as a probe (Coskun et al., 2006). As a control for contaminating
DNA, Superscript II was omitted from the first strand reaction.
Total RNA from 293T cells that had been transduced with an
HIV vector encoding both luciferase and bsd was used as a
positive control for both spliced and unspliced viral RNAs.
Genome-wide nucleic acid and chromosome analyses
PCR was performed on genomic DNA using the ABI
PRISM Linkage Mapping Set (Applied Biosystems) following
the manufacturer's recommendations for amplification condi-
tions. DNA products (typically less than 300 bp in length) were
size-separated by agarose gel electrophoresis and stained with
ethidium bromide (EtBr). Water was included as a negative
control and genomic DNA from 293T cells served as a positive
control.
For metaphase spread preparations, cells were incubated in
10 μg/ml colcemid solution (Invitrogen) for 20 min at 37 °C.
Cells were trypsinized, treated with 75 mM KCl hypotonic
solution for 20 min, and fixed with 3:1 methanol:glacial acetic
acid. FISH analyses were performed using whole chromosome
painting (WCP) probes for human chromosome 2 (Vysis) or to
labeled BACs (purchased from Children's Hospital Oakland
Research Institute, Oakland, California), according to the
manufacturer's protocol and examined using fluorescence
microscopy. For each cell line, 25–50 representative metaphase
spreads were examined.
Microarray analyses were performed using total RNA
converted to fluorescently labeled cDNA and hybridized to
the U133 Plus 2.0 Affymetrix array chip. Raw hybridization
scores for individual genes were plotted in numerical order
(numbering per UCSC genome browser) for the entire set of
chromosomes, with each chromosome represented graphically
by a single line.
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